A.R.T. Advisors’s AYTU BioPharma AYTU Stock Holding History

A.R.T. Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-61	Closed	-$23K	–	1429
2019 Q2	$23K	Buy	+61	New	+$23.2K	﹤0.01%	1289
2019 Q1	–	Sell	-120	Closed	-$19K	–	1309
2018 Q4	$19K	Buy	+120	New	+$26.4K	﹤0.01%	1253

Other funds holding AYTU

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Searle & Co Greenwich, Connecticut $398M AUM 22.87% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's AYTU Position: Q3 2019 in Review

A.R.T. Advisors sold out of AYTU BioPharma (AYTU) in Q3 2019, closing a stake of 61 shares — an estimated $23K sold.

A.R.T. Advisors first reported a position in AYTU in Q4 2018 and held it in 2 quarters. The position peaked at $23K in Q2 2019. 12 funds tracked by Wall St. Rank hold AYTU as of Q3 2019.

A.R.T. Advisors reported no remaining AYTU BioPharma position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 61 AYTU BioPharma shares in Q3 2019, an estimated $23K.
A.R.T. Advisors first reported a position in AYTU BioPharma in Q4 2018 and held it in 2 quarters.
A.R.T. Advisors's AYTU BioPharma position peaked at $23K in Q2 2019.
12 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.